OBI Header
     ABOUT     TECHNOLOGY OVERVIEW       CONTACT US       HOME    
spacer
Patents spacer  Patents

 

OmniGene Bioproducts holds U.S. and foreign patents on proprietary Bacillus and Streptomyces vector systems and patents covering Bacillus strains deleted for four different extracellular proteases.

Some key U.S. patents:
(links retrieve full-text patent information from U.S. Patent Office)

OmniGene Bioproducts, Inc. and OmniGene, Inc.

U.S. 6,830,893

Microorganisms and assays for the identification of antibiotics (2004)

U.S. 5,874,278

Protease deletion (1999)

U.S. 5,620,880

Protease deletion (1997)

U.S. 5,589,383

Protease deletion (1996)

U.S. 5,294,542

Residual protease-III (1994)

BioTechnica International, Inc.

U.S. 5,017,477

Enhancing DNA sequences derived from the sacQ gene (1991)

Patents assigned to collaborators

U.S. 7,291,489

Microorganisms and processes for enhanced production of pantothenate (2007; assigned to BASF)

U.S. 7,244,593

Microorganisms and processes for enhanced production of pantothenate (2007; assigned to BASF)

U.S. 7,220,561

Processes for enhanced production of pantothenate (2007; assigned to BASF)

U.S. 7,091,000

Bacterial strains which overproduce riboflavin and methods of use thereof (2006; assigned to DSM Nutritional Products)

U.S. 6,841,366

Biotin biosynthesis in Bacillus subtilis (2005; assigned to DSM IP Assets, B.V.)

U.S. 6,737,256

Overcoming DAPA aminotransferase bottlenecks in biotin vitamers biosynthesis (2004; assigned to Roche Vitamin Products)

U.S. 6,551,813

Nutrient medium for bacterial strains which overproduce riboflavin (2003; assigned to Roche Vitamins, Inc.)

U.S. 6,303,377

Biotin biosynthesis in Bacillus subtilis (2001; assigned to Roche Vitamins, Inc.)

U.S. 6,057,136

Biotin biosynthesis in Bacillus subtilis (2000; assigned to Roche Vitamins, Inc.)

U.S. 5,925,538

Bacterial strains which overproduce riboflavin (1999; assigned to Roche Vitamins, Inc.)

U.S. 5,837,528

Bacterial strains which overproduce riboflavin (1998; assigned to Hoffmann La Roche, Inc.)

 

>> Click here to learn more about our key publications.

<< Click here to return to the Technology Overview.